Active	Status	Sponsor type	Region	Phase	Filter
17 Active 0 Inactive 17 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

17 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Delgado, Patricia
NAVIGATE, NCT04365868 / 2019-001983-31: Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis	Active, not recruiting	2/3	357	Europe, Canada, US, RoW	belapectin, GR-MD-02, galactoarabino rhamnogalacturonate, Placebo	Galectin Therapeutics Inc., Galectin Therapeutics Inc	Prevention of Esophageal Varices, NASH - Nonalcoholic Steatohepatitis, Cirrhosis	03/25	09/25
ALKIVIA, NCT05523167 / 2021-001277-23: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.	Recruiting	2/3	240	Europe, Canada, Japan, US, RoW	EFG PH20 SC, PBO	argenx, argenx BV	Active Idiopathic Inflammatory Myopathy, Myositis, Dermatomyositis, Polymyositis, Immune-Mediated Necrotizing Myopathy, Antisynthetase Syndrome	12/26	02/27
CTU, Dermatology
NCT05446402: Investigation of the Tolerability of Two Facial Cleansing Routines for Mild to Moderate Acne	Completed	4	29	US	Geologie Acne Regimen - one side of face, Proactive Acne Regimen - other side of face	Northwestern University	Acne	05/23	12/23
NCT03115567: A Study of Topical Steroids as Preemptive Therapy for EGFR Inhibitor-Induced Papulopustular Eruption	Terminated	2	14	US	Triamcinolone	Northwestern University	Acneiform Rash, Papulopustular Eruption	04/20	09/22
NCT05728879: Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution	Not yet recruiting	1	30	US	APR-TD011 (RLF-TD011), Nexodyn AOS	Northwestern University	Cutaneous T Cell Lymphoma	12/26	12/26
NCT05533866: Characterization of the Microbiome in Colonized Dystrophic and Junctional Epidermolysis Bullosa Wounds Before and After Use of APR-TD011 ® Spray Solution	Active, not recruiting	1	16	US	APR-TD011, Nexodyn AOS	Northwestern University	Epidermolysis Bullosa	09/24	02/25
NCT06684522: Upadacitinib As a Novel Treatment for Refractory Eyelid Dermatitis	Not yet recruiting	1	10	US	Upadacitinib 15 MG, RINVOQ	Northwestern University	Eyelid Dermatitis	03/26	03/26
NCT06661213: Tapinarof for Cutaneous Lupus Erythematosus	Not yet recruiting	1	10	US	Tapinarof, VTAMA	Northwestern University	Cutaneous Lupus Erythematosus	03/26	03/26
NCT05649098: Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders	Recruiting	1	30	US	Dupilumab	Northwestern University	Skin Diseases	06/25	06/26
NCT05838599: Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides	Recruiting	1	25	US	Imiquimod, Radiation Therapy	Northwestern University	Mycosis Fungoides	08/25	02/26
NCT05843994: Artificial Intelligence Patient App for RDEB SCCs	Active, not recruiting	N/A	20	US	online survey	Northwestern University, Epidermolysis Bullosa Research Partnership	Epidermolysis Bullosa Dystrophica	11/23	11/25
NCT03577327: The Gut and Skin Microbiome in Vitiligo Disease Progression	Recruiting	N/A	100	US		Northwestern University	Vitiligo, Healthy	06/24	12/24
NCT03932279: Characterization of the Microbiome in Cutaneous T Cell Lymphoma	Recruiting	N/A	300	US		Northwestern University	Cutaneous T Cell Lymphoma	02/28	08/28
TARGET-DERM, NCT03661866: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC	Recruiting	N/A	15000	Europe, Canada, US		Target PharmaSolutions, Inc.	Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria	12/50	12/50
Aly, Radwa
NCT04226170: Study of Pyridostigmine With Ondansetron in Subjects With Anti-AchR Positive Myasthenia Gravis	Recruiting	2	24	US	DAS-001	DAS-MG, Inc	Myasthenia Gravis	07/25	09/26
SELFIE, NCT04423679: The Selfie Study- Assessing Novel Markers for Cervical Cancer Screening From Self-collected Samples	Recruiting	N/A	1000	US	Evalyn Brush	George Washington University, National Cancer Institute (NCI)	Human Papilloma Virus, Cervical Cancer, CIN 2/3	08/24	08/25
TARGET-DERM, NCT03661866: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC	Recruiting	N/A	15000	Europe, Canada, US		Target PharmaSolutions, Inc.	Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria	12/50	12/50
Torres-Bonilla, Gisela
No trials found
Stilwell, Michele
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Delgado, Patricia
NAVIGATE, NCT04365868 / 2019-001983-31: Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis	Active, not recruiting	2/3	357	Europe, Canada, US, RoW	belapectin, GR-MD-02, galactoarabino rhamnogalacturonate, Placebo	Galectin Therapeutics Inc., Galectin Therapeutics Inc	Prevention of Esophageal Varices, NASH - Nonalcoholic Steatohepatitis, Cirrhosis	03/25	09/25
ALKIVIA, NCT05523167 / 2021-001277-23: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.	Recruiting	2/3	240	Europe, Canada, Japan, US, RoW	EFG PH20 SC, PBO	argenx, argenx BV	Active Idiopathic Inflammatory Myopathy, Myositis, Dermatomyositis, Polymyositis, Immune-Mediated Necrotizing Myopathy, Antisynthetase Syndrome	12/26	02/27
CTU, Dermatology
NCT05446402: Investigation of the Tolerability of Two Facial Cleansing Routines for Mild to Moderate Acne	Completed	4	29	US	Geologie Acne Regimen - one side of face, Proactive Acne Regimen - other side of face	Northwestern University	Acne	05/23	12/23
NCT03115567: A Study of Topical Steroids as Preemptive Therapy for EGFR Inhibitor-Induced Papulopustular Eruption	Terminated	2	14	US	Triamcinolone	Northwestern University	Acneiform Rash, Papulopustular Eruption	04/20	09/22
NCT05728879: Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution	Not yet recruiting	1	30	US	APR-TD011 (RLF-TD011), Nexodyn AOS	Northwestern University	Cutaneous T Cell Lymphoma	12/26	12/26
NCT05533866: Characterization of the Microbiome in Colonized Dystrophic and Junctional Epidermolysis Bullosa Wounds Before and After Use of APR-TD011 ® Spray Solution	Active, not recruiting	1	16	US	APR-TD011, Nexodyn AOS	Northwestern University	Epidermolysis Bullosa	09/24	02/25
NCT06684522: Upadacitinib As a Novel Treatment for Refractory Eyelid Dermatitis	Not yet recruiting	1	10	US	Upadacitinib 15 MG, RINVOQ	Northwestern University	Eyelid Dermatitis	03/26	03/26
NCT06661213: Tapinarof for Cutaneous Lupus Erythematosus	Not yet recruiting	1	10	US	Tapinarof, VTAMA	Northwestern University	Cutaneous Lupus Erythematosus	03/26	03/26
NCT05649098: Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders	Recruiting	1	30	US	Dupilumab	Northwestern University	Skin Diseases	06/25	06/26
NCT05838599: Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides	Recruiting	1	25	US	Imiquimod, Radiation Therapy	Northwestern University	Mycosis Fungoides	08/25	02/26
NCT05843994: Artificial Intelligence Patient App for RDEB SCCs	Active, not recruiting	N/A	20	US	online survey	Northwestern University, Epidermolysis Bullosa Research Partnership	Epidermolysis Bullosa Dystrophica	11/23	11/25
NCT03577327: The Gut and Skin Microbiome in Vitiligo Disease Progression	Recruiting	N/A	100	US		Northwestern University	Vitiligo, Healthy	06/24	12/24
NCT03932279: Characterization of the Microbiome in Cutaneous T Cell Lymphoma	Recruiting	N/A	300	US		Northwestern University	Cutaneous T Cell Lymphoma	02/28	08/28
TARGET-DERM, NCT03661866: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC	Recruiting	N/A	15000	Europe, Canada, US		Target PharmaSolutions, Inc.	Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria	12/50	12/50
Aly, Radwa
NCT04226170: Study of Pyridostigmine With Ondansetron in Subjects With Anti-AchR Positive Myasthenia Gravis	Recruiting	2	24	US	DAS-001	DAS-MG, Inc	Myasthenia Gravis	07/25	09/26
SELFIE, NCT04423679: The Selfie Study- Assessing Novel Markers for Cervical Cancer Screening From Self-collected Samples	Recruiting	N/A	1000	US	Evalyn Brush	George Washington University, National Cancer Institute (NCI)	Human Papilloma Virus, Cervical Cancer, CIN 2/3	08/24	08/25
TARGET-DERM, NCT03661866: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC	Recruiting	N/A	15000	Europe, Canada, US		Target PharmaSolutions, Inc.	Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria	12/50	12/50
Torres-Bonilla, Gisela
No trials found
Stilwell, Michele
No trials found